share_log

HC Wainwright & Co. Maintains Buy on Replimune Group, Lowers Price Target to $48

HC Wainwright & Co. Maintains Buy on Replimune Group, Lowers Price Target to $48

HC Wainwright & Co.維持對Replimune集團的買入,將目標價下調至48美元
Benzinga ·  2023/11/13 18:07

HC Wainwright & Co. analyst Robert Burns maintains Replimune Group (NASDAQ:REPL) with a Buy and lowers the price target from $50 to $48.

HC Wainwright & Co. 分析師羅伯特·伯恩斯維持Replimune集團(納斯達克股票代碼:REPL)的買入,並將目標股價從50美元下調至48美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論